Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,430,801
  • Shares Outstanding, K 53,408
  • Annual Sales, $ 579,780 K
  • Annual Income, $ 53,420 K
  • 60-Month Beta 1.12
  • Price/Sales 2.44
  • Price/Cash Flow 13.45
  • Price/Book 1.71
Trade SUPN with:

Options Overview Details

View History
  • Implied Volatility 77.27% ( -22.52%)
  • Historical Volatility 42.25%
  • IV Percentile 82%
  • IV Rank 60.90%
  • IV High 105.43% on 05/10/22
  • IV Low 33.40% on 09/23/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 53
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 4,327
  • Open Int (30-Day) 3,996

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.29
  • Number of Estimates 2
  • High Estimate 0.38
  • Low Estimate 0.21
  • Prior Year 0.43
  • Growth Rate Est. (year over year) -32.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.95 +7.37%
on 05/11/22
32.90 -18.57%
on 04/14/22
-5.84 (-17.90%)
since 04/13/22
3-Month
24.95 +7.37%
on 05/11/22
34.45 -22.24%
on 04/07/22
-3.40 (-11.26%)
since 02/11/22
52-Week
23.15 +15.72%
on 08/20/21
34.50 -22.35%
on 11/17/21
-3.04 (-10.19%)
since 05/13/21

Most Recent Stories

More News
Supernus Announces First Quarter 2022 Financial Results

First quarter 2022 total revenues of $152.5 million, a 16% increase compared to first quarter 2021First quarter 2022 net earnings and diluted earnings per...

SUPN : 26.79 (+1.29%)
Supernus Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022

ROCKVILLE, Md., May 02, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

SUPN : 26.79 (+1.29%)
Activision, Hilltop Holdings rise; Jeld-Wen, Moody's fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

GPN : 122.20 (+3.72%)
SUPN : 26.79 (+1.29%)
JELD : 17.50 (+0.69%)
HR : 28.56 (+0.32%)
HTH : 29.33 (+2.16%)
ATVI : 77.74 (+0.47%)
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults

First novel, nonstimulant option for adults with ADHD in 20 yearsADHD affects an estimated 10 million adults in the U.S. ROCKVILLE, Md., April 29, 2022 ...

SUPN : 26.79 (+1.29%)
Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results

Annual Report on Form 10-K filed on April 13, 2022Reiterates full year 2022 financial guidance provided on February 28, 2022 and reiterated on April 4,...

SUPN : 26.79 (+1.29%)
Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance

Annual Report on Form 10-K for fiscal year ended December 31, 2021 to be filed in the near termReiterates full year 2022 financial guidance provided on...

SUPN : 26.79 (+1.29%)
Supernus Notifies Nasdaq Regarding Non-Compliance with Listing Requirement and Expectation to Regain Compliance

ROCKVILLE, Md., March 17, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

SUPN : 26.79 (+1.29%)
Supernus to Participate in Annual Cowen Health Care Conference

ROCKVILLE, Md., March 02, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

SUPN : 26.79 (+1.29%)
Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results

Preliminary full year 2021 total revenues were $579.8 million; an 11% increase compared to $520.4 million in 2020SPN-830 (apomorphine infusion device) NDA...

SUPN : 26.79 (+1.29%)
Supernus to Provide Preliminary Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022

ROCKVILLE, Md., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

SUPN : 26.79 (+1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

3rd Resistance Point 28.26
2nd Resistance Point 27.66
1st Resistance Point 27.23
Last Price 26.79
1st Support Level 26.19
2nd Support Level 25.59
3rd Support Level 25.16

See More

52-Week High 34.50
Fibonacci 61.8% 30.16
Fibonacci 50% 28.83
Fibonacci 38.2% 27.49
Last Price 26.79
52-Week Low 23.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar